GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
19:39 Mar 22, 2014 |
German to English translations [PRO] Marketing - Medical: Pharmaceuticals | |||||||
---|---|---|---|---|---|---|---|
|
| ||||||
| Selected response from: Michael Martin, MA United States Local time: 03:57 | ||||||
Grading comment
|
Summary of answers provided | ||||
---|---|---|---|---|
3 +2 | patient populations |
| ||
2 +3 | potential number of patients |
| ||
3 | patient reach |
|
Discussion entries: 2 | |
---|---|
patient populations Explanation: Bei Pharma wurden im Jahr 2000 468 Millionen € für Forschung und Entwicklung aufgewandt. Ziel war die Ent- wicklung innovativer Therapien für medizinische Indikatio- nen mit hohem Patientenpotenzial, wie Herz-Kreislauf- Krankheiten, septischer Schock und rheumatoide Arthritis. Die Forschungseinrichtungen sind auch Bestandteil der Pharma-Aktivitäten, deren Veräußerung im ersten Quartal 2001 vollzogen werden soll In 2000, we invested € 468 million in research and devel- opment activities in the field of pharmaceuticals. These investments focused on developing innovative solutions in specific therapeutic areas with high medical need and large patient populations such as cardiovascular diseases, septic shock and rheumatoid arthritis. Our pharmaceu- ticals activities include research facilities, which are also scheduled to be sold in the first quarter of 2001. Reference: http://www.basf.com/group/corporate/de/function/conversions:... Reference: http://www.basf.com/group/corporate/en/function/conversions:... |
| |